Consistently, the ablation of NPPA or NPR1 (the gene encoding NPR-A) as well as NP genetic variants leading to reduced peptide expression have been associated with cardiac hypertrophy and impaired endothelial cell viability and proliferation [50,51,52,53,54]. This evidence concerns the gene NPPA and cardiac hypertrophy.